方法：选择年龄相关性黄斑变性并发脉络膜新生血管化(AMD-CNV)患者17例17眼，男7例，女10例，年龄53～72岁。患者经过视力、眼压、荧光素眼底血管造影(FFA)、吲哚青绿血管造影(ICGA)和光学相干断层成像(OCT)等检查确诊。患者用PDT治疗5d后，再用500mg中药血栓通注射液静脉滴注10d，1次/d，疗程为15d，观察治疗后1，3和6mo疗效。

结果：治疗6mo，17例中视力提高8例(47%)，视力稳定无明显变化6例(35%)，视力下降3例(18%)； 12例(71%)CNV闭合且渗漏完全停止，5例(29%)CNV大部分闭合。1例出现一过性视物模糊。

结论：PDT联合中药血栓通注射液治疗AMD-CNV方法简单，疗效可靠，可在临床推广应用。

METHODS: Seventeen patients(17 eyes)with AMD and CNV were diagnosed by visual acuity, ocular pressure, fundus fluorescein angiography(FFA), idocyanine green angiography(ICGA)and optic coherence tomography(OCT), and male 7 cases, female 10 cases, age 53-72 years old. PDT was performed using the recommended standard procedure. The patients were treated with PDT for 5 days, and Sanqi Panax Notoginseng 500mg injection by intravenous drip for 10 days, once a day, 15 days as one course. One month, 3, 6 months of follow-up after treatment.

RESULTS: Of 17 patients after 6 months treatment, visual acuity improved in 8 cases(47%, 8/17), remained stable in 6 cases(35%), and decreased in 3 cases(18%); and 12 cases(71%)with CNV closure and leakage stopped completely, 5 cases(29%)with most of the CNV's closure, 1 patient experienced blurred vision.

CONCLUSION: The results show that PDT combined with traditional Chinese medicine Sanqi Panax Notoginseng in treatment of ADM-CNV is simple and has reliable effect, it can be used in clinical application.